000 | 01534 a2200421 4500 | ||
---|---|---|---|
005 | 20250511212259.0 | ||
264 | 0 | _c19910827 | |
008 | 199108s 0 0 eng d | ||
022 | _a0344-5704 | ||
024 | 7 |
_a10.1007/BF00685517 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGustafson, D L | |
245 | 0 | 0 |
_aInhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51. _h[electronic resource] |
260 |
_bCancer chemotherapy and pharmacology _c1991 |
||
300 |
_a228-30 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
650 | 0 | 4 |
_aAerobiosis _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xantagonists & inhibitors |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aAzoles _xpharmacology |
650 | 0 | 4 |
_aCell Hypoxia _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDimethyl Sulfoxide _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aIsoindoles |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMitomycin |
650 | 0 | 4 |
_aMitomycins _xantagonists & inhibitors |
650 | 0 | 4 | _aOrganoselenium Compounds |
650 | 0 | 4 |
_aPorfiromycin _xtoxicity |
650 | 0 | 4 |
_aSelenium _xpharmacology |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aPritsos, C A | |
773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 28 _gno. 3 _gp. 228-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00685517 _zAvailable from publisher's website |
999 |
_c1912983 _d1912983 |